Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
Frequently Asked Questions / Cancer Treatment Options / Radiation Oncology
Li Liu, MD
Last Modified: November 1, 2001
Dear OncoLink "Ask the Experts,"
My wife has had polycythemia vera which was diagnosed in 1964. She was treated initially with frequent phlebotomies during the first decade of her illness. She developed splenomegaly and underwent surgical splenectomy in 1984. In the early 1990s she went into post polycythemic myeloid metaplasia with bone marrow fibrosis. She has been on hydroxyurea and has been receiving Epogen for anemia. She has developed mesenteric mass, which has been followed by CT scan. It is the foci of extramedullary hematopoiesis, although no biopsy was taken because of her coagulopathy. It has enlarged to the size of a full term pregnancy during the past several months. Her doctor is suggesting radiation therapy, hoping to reduce the abdominal mass. He states that he has had experience in radiation therapy for the splenomegaly, but not for the mesenteric mass.
My question to you is: do you have any experience in radiating erythropoietic mesenteric mass secondary to post-polycythemic myeloid metaplasia in order to reduce its size? I would appreciate your response.
Thank you,
Dr. K
Li Liu, MD, OncoLink Editorial Assistant, responds:
Dear Dr. K:
Thank you for your interest and question.
It is not uncommon to see patients with polycythemia vera presenting with extramedullary hematopoiesis. Radiation therapy can be used, but under certaincircumstances. First of all, your wife should have a very thorough physical examination and radiographic studies to fully evaluate the status of her disease. Tissue diagnosis prior to treatment to ensure correct diagnosis and rule out other causes for an abdominal mass may also be considered.
In addition, as you mentioned in your letter, your wife's bone marrow is fibrotic. If her bone marrow is not functioning at all, then this mesenteric mass could be the only focus of extramedullary hematopoiesis to keep her alive. Therefore irradiating this mass could cause fatal consequence. One physician at the University of Pennsylvania has treated several cases for pain due to these masses, with good results. Only one or two cases were treated to reduce the size of the mass, and these seemed to respond partially to somewhat higher doses.
I would recommend you and your wife consult a radiation oncologist to discuss the pros and cons of radiation treatment and to explore other treatment options as well.
Dr. Mao discusses why a patient’s culture plays an important role in treatment decisions. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

